Low-dose cyclophosphamide in combination with cisplatin or epirubicin plus rhG-CSF allows adequate collection of PBSC for autotransplantation during adjuvant therapy for high-risk cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples